C vs NEPH · P/E 16, rev $85.22B vs P/E 48, rev $14.2M
Citigroup Inc. (C) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
C currently screens at market cap $214.73B and trailing P/E 15.5. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Not investment advice. Open the C and NEPH stock pages for the full models.
Not investment advice.